BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33707942)

  • 1. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
    Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
    Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel csuC-DNA nanovaccine based on chitosan candidate vaccine against infection with Acinetobacter baumannii.
    Hosseinnezhad-Lazarjani E; Doosti A; Sharifzadeh A
    Vaccine; 2023 Mar; 41(13):2170-2183. PubMed ID: 36841724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose Ag85B-ESAT6-loaded poly(lactic-
    Malik A; Gupta M; Mani R; Bhatnagar R
    Int J Nanomedicine; 2019; 14():3129-3143. PubMed ID: 31118627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.
    Fairley SJ; Singh SR; Yilma AN; Waffo AB; Subbarayan P; Dixit S; Taha MA; Cambridge CD; Dennis VA
    Int J Nanomedicine; 2013; 8():2085-99. PubMed ID: 23785233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydopamine-based nano adjuvant as a promising vaccine carrier induces significant immune responses against Acinetobacter baumannii-associated pneumonia.
    Sabzi S; Habibi M; Badmasti F; Shahbazi S; Asadi Karam MR; Farokhi M
    Int J Pharm; 2024 Apr; 654():123961. PubMed ID: 38432452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
    Singh R; Capalash N; Sharma P
    Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles.
    Kabiri M; Sankian M; Sadri K; Tafaghodi M
    Eur J Pharm Biopharm; 2018 Dec; 133():321-330. PubMed ID: 30408519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprotectivity of Valine-glycine repeat protein G, a potent mediator of pathogenicity, against Acinetobacter baumannii.
    Pazoki M; Darvish Alipour Astaneh S; Ramezanalizadeh F; Jahangiri A; Rasooli I
    Mol Immunol; 2021 Jul; 135():276-284. PubMed ID: 33940514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
    KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
    Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
    Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
    Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.
    Roozbehani M; Falak R; Mohammadi M; Hemphill A; Razmjou E; Meamar AR; Masoori L; Khoshmirsafa M; Moradi M; Gharavi MJ
    Vaccine; 2018 Oct; 36(41):6124-6132. PubMed ID: 30181047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
    Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
    Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicistronic DNA vaccine macromolecule complexed with poly lactic-co-glycolic acid-chitosan nanoparticles enhanced the mucosal immunity of Labeo rohita against Edwardsiella tarda infection.
    Leya T; Ahmad I; Sharma R; Tripathi G; Kurcheti PP; Rajendran KV; Bedekar MK
    Int J Biol Macromol; 2020 Aug; 156():928-937. PubMed ID: 32289420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
    Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
    Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR
    Hassan A; Ikram A; Raza A; Saeed S; Zafar Paracha R; Younas Z; Khadim MT
    Int J Nanomedicine; 2021; 16():3755-3773. PubMed ID: 34103914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MF59 adjuvant enhances the immunogenicity and protective immunity of the OmpK/Omp22 fusion protein from Acineterbacter baumannii through intratracheal inoculation in mice.
    Yang AQ; Yang HY; Guo SJ; Xie YE
    Scand J Immunol; 2019 Jul; 90(1):e12769. PubMed ID: 31006127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
    Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.